Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SCM-CGH in Steroid-Refractory Chronic Graft Versus Host Disease (Phase IIb, Double-Blind, Randomized)
KCT0003656Phase 2Recruiting
- Sponsor
- SCM Lifescience Co., Ltd.
- Start
- Dec 2017
- Modality
- Mesenchymal Stem Cells → Adult Stem Cells → Stem Cell Therapies → Cell Therapies
- Countries
- 1
01
Overview
A Phase 2 trial of SCM-AGH in steroid-refractory chronic graft-versus-host disease (SR-cGVHD), sponsored by SCM Lifescience Co., Ltd.. Started Dec 2017; status: recruiting.
02
Drugs
SCM-AGH
03
Conditions
steroid-refractory chronic graft-versus-host disease (SR-cGVHD)
Beyond the preview
Go deeper on KCT0003656.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on KCT0003656.